Minoia et al. [103] and Zatelli et al. [104] had reported about GH induced chemoresistance from doxorubicin in MDA-MB-231 and MCF7 breast cancer cells respectively resulting in reduced tumor apoptosis, which was reversed by pegvisomant. This evidence concerns the gene GH1 and breast carcinoma.